| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |